SCHEMBL21026346

SCHEMBL21026346

CC(C)c1ccc(S(=O)(=O)NC(C)(C)C)cc1OC(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARG Q86W56 2/20 0.46
SMN1; SMN2 Q16637 3/20 0.43
MAPT P10636 2/20 0.43
KDM4E B2RXH2 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
LMNA P02545 2/20 0.43
HPGD P15428 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
ALDH1A1 P00352 5/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
MAPK1 P28482 1/20 0.40
KCNK3 O14649 1/20 0.38
KCNK9 Q9NPC2 1/20 0.38
SIRT2 Q8IXJ6 1/20 0.37
FFAR4 Q5NUL3 1/20 0.36
CNR1 P21554 1/20 0.36
USP30 Q70CQ3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21028120 0.87 PARG (0.50) PARGMAPTKDM4EKMT2ALMNA
SCHEMBL21028211 0.83 RORC (0.41) SMN1; SMN2MEN1KMT2AALDH1A1MAPK1
SCHEMBL16852442 0.82 LMNA (0.46) PARGSMN1; SMN2MAPTKDM4EMEN1
SCHEMBL21028254 0.79 SMN1; SMN2 (0.50) PARGSMN1; SMN2MAPTKDM4EMEN1
SCHEMBL16849144 0.77 PARG (0.53) PARGSMN1; SMN2MAPTKDM4EMEN1
SCHEMBL16849141 0.76 ALDH1A1 (0.51) PARGSMN1; SMN2MAPTKDM4EMEN1
SCHEMBL26144791 0.76 PARG (0.51) PARGSMN1; SMN2MAPTKDM4EMEN1
SCHEMBL16849166 0.74 ALOX5AP (0.35) PARGSMN1; SMN2MAPTKDM4EMEN1
SCHEMBL19590554 0.74 CNR1 (0.41) PARGSMN1; SMN2MAPTKDM4EMEN1
SCHEMBL16060627 0.73 FFAR4 (0.57) SMN1; SMN2MAPTLMNAALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10301272-B2 Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ] PHENEX PHARMACEUTICALS AG (DE) 2019-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10301272-B2 Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ] RORA, RORB, RORC PARG 4878/4885SMN1; SMN2 1570/4885MAPT 1429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.